More muscle, less belly fat: mutations to a gene are linked to wide-ranging benefits

TL;DR - A Nature news item reporting a large-scale genomic analysis of roughly one million diverse genomes that identified mutations in a gene associated with higher muscle mass, lower belly fat, and reduced cardiometabolic risk. It matters as a demonstration of population-scale genomics at a size where computational/statistical pipelines are the bottleneck and where diverse cohorts surface variants missed by smaller, less representative studies.

• Scale: the association scan spans ~1 million genomes, a cohort size that requires industrial-grade variant calling, imputation, and association-testing infrastructure.
• Phenotypic signal: carriers of the reported mutations show increased muscle and reduced abdominal fat, plus lower risk of diabetes, heart disease, and related "cardiometabolic" conditions.
• Diversity emphasis: the article stresses that the cohort is genetically diverse, which is the stated basis for detecting these variants and improving generalizability of polygenic/variant findings.
• Caveat: this is a news summary only — the provided content gives no effect sizes, gene name, statistical thresholds, replication cohorts, or methodological detail, so any mechanistic or therapeutic claims are unverified here.